Combine the deep patient trust of independent neighborhood pharmacists with phlebotomy-certified clinical coordinators to transform local diagnostic screening, biomarker draws, and longitudinal follow-up.
RxE2 Community Diagnostics:
Local Screening Powered by Trusted Pharmacist Relationships

Overcoming the Screening
Bottleneck in Clinical Research
Over 80% of traditional clinical trials experience enrollment delays and participant drop-off. Centralized academic sites compete for the same narrow patient pools, while traditional corporate laboratory networks struggle with execution delays and impersonal patient experiences.
When patients are forced to travel long distances or visit unfamiliar medical facilities for routine diagnostic draws, compliance breaks down.
Anchored in Community Trust,
Executed with Clinical Precision
RxE2 Community Diagnostics places clinical trial screening directly into the neighborhood healthcare settings patients already know and trust. Local collection removes geographic friction and builds long-term trial engagement.
5 miles of a community pharmacy
A Turnkey 5-Step Model for Clinical Trial Sponsors
Protocol Alignment
The sponsor defines diagnostic criteria, sample collection protocols, and visit schedules.
Site Selection
RxE2 identifies qualified independent pharmacy consultation suites based on state regulations and target patient demographics.
Pharmacist Engagement & Patient Connection
Local pharmacists leverage their established patient relationships and community trust to introduce screening opportunities.
In-Pharmacy Diagnostic Encounter
A phlebotomy-certified clinical coordinator conducts the blood draw and completes GCP documentation in a private consultation suite.
Logistics & Quality Oversight
Central lab couriers collect specimens under strict chain of custody, while RxE2 manages complete program orchestration and quality monitoring.
Transparent Budget Predictability for Sponsors
RxE2 offers a transparent, value-aligned commercial structure designed to eliminate traditional CRO markups and provide total budget clarity:
Fixed Program
Orchestration
A predictable fee covering:
- Central management
- GCP quality monitoring
- Site coordination
- Data reporting
Pass-Through
Operational Costs
Transparent reimbursement, billed directly at operational cost, for:
- Local pharmacy consultation space
- Clinical coordinator encounter hours
Accelerated Timelines and
Industry-Leading Participant Retention
8–10weeks
Accelerated Site Activation
Activate operational local screening hubs in 8 to 10 weeks.
vs. 12 to 36 weeks for central sites
90day+
Superior Longitudinal Retention
Achieve industry-leading participant retention over 90-day and multi-month protocols by keeping diagnostic draws in the patient’s local neighborhood.
40%+
Representative Community Reach
Leverage trusted community pharmacists to engage underrepresented populations, achieving over 40% diverse participant representation across clinical protocols.
Frequently Asked Questions
What is the specific role of the local community pharmacist?
The local pharmacist serves as the trusted healthcare anchor. They provide patient familiarity, introduce screening opportunities, and host the encounter in their private consultation suite, while dedicated clinical coordinators execute the clinical draw.
Who performs the actual blood draws and diagnostic procedures?
All blood draws and specimen handling are performed by phlebotomy-certified clinical research coordinators. This maintains strict GCP source documentation standards while freeing the pharmacist to focus on patient connection and care.
How does RxE2 ensure quality control across independent pharmacy locations?
RxE2 provides centralized quality oversight, standardized diagnostic collection kits, and unified GCP compliance protocols across every participating site.

Ready to Bring Clinical Screening
to the Community?
Talk with our clinical operations team to see how RxE2 Community Diagnostics can streamline your screening protocols, expand access, and improve trial retention.